´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷) : 2024-05-10
±³À°ÀÏÀÚ : 2024-05-10
±³À°Àå¼Ò : ¼ö¿øÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸
´ã´çÀÚ : ±èÇý¼÷
¿¬¶ôó : 02-512-5420
À̸ÞÀÏ : kelly.kim1436@hanmail.net
±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í KGOG : Korean Gynecologic Oncology Group »ç´Ü¹ýÀÎ ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ ¾àÀÚÀÔ´Ï´Ù.*ÇÁ·Î±×·¥¿¡ KGOG·Î µÇ¾îÀÖ´Â ºÎºÐ Âü°í ºÎŹµå¸³´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 13:00~13:15 Data and Statistics Committee: Korean central IRB : suggestion for KGOG ÀÌ´ëÈ£(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 13:15~13:30 Data and Statistics Committee: Data management team build up experience ¾È¼Ò¿¬(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 13:30~13:45 Establishing a foundation for activating investigator-initiated multi-center GYN cancer clinical trial group (2024' ~ 2028') ÃÖ¹Îö(ºÐ´çÂ÷º´¿ø)
Åä·Ð 05¿ù 10ÀÏ Room B 13:45~13:55 Discussion ±è±âµ¿, ÀÓÇöÁö(ºÐ´ç¼¿ï´ëº´¿ø, ÀÏ»êÂ÷º´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 14:00~14:20 To understand overall global Trends in R&D 2024 and elements of Decentralized Clinical Trials(DCT): Global Trends in R&D 2024 È«Çö¼÷(IQVIA)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 14:20~14:40 Elements of Decentralized Clinical Trials and its Global Trends È«Çö¼÷(IQVIA)
Åä·Ð 05¿ù 10ÀÏ Room B 14:40~14:50 Discussion ()
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:00~14:05 KGOG 4004 (OVsurg-2102-1): A survey study of Peritonectomy (ÀÚÀ¯) ±è¸í¼±(¼ººó¼¾Æ®º´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:05~14:10 KGOG 4005 (OVsurg-2101): The analysis of the patients who have received reoperation whining 30 days after debulking operation for primary advanced epithelial ovarian, tubal, peritoneal cancer (ÀÚÀ¯) À¯ÇåÁ¾(¼¼Á¾Ãæ³²´ëº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:10~14:15 KGOG 4006 (OVsurg-2103): The analysis of 90-day postoperative mortality after debulking operation for primary advanced epithelial ovarian, tubal, peritoneal cancer (ÀÚÀ¯) ¼Û¿ëÁß(ºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:15~14:20 KGOG 4010 (OVsurg-2108): Assessment of QoL after LAR or visceral peritoneal stripping during cytoreductive surgery for AEOC: prospective cohort study (LAPSODY) trial (ÀÚÀ¯) ±èÈñ½Â(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:20~14:25 Lymphadenectomy In clinically early epitheLial ovArian Cancer and survival analaysis (LILAC) (ÀÚÀ¯) ½É½ÂÇõ(°Ç±¹´ëº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:25~14:30 Sentinel lymph node mapping in early stage ovarian cancer (ÀÚÀ¯) ±è´ë¿¬(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:30~14:35 OVsurg-2102-3: Total parietal peritonectomy during IDS/NACT for epithelial ovarian/fallopian tube/primary peritoneal carcinoma: A feasibility study (TPP-IDS) (ÀÚÀ¯) ÀÌÀºÁÖ(Á߾Ӵ뺴¿ø)
Åä·Ð 05¿ù 10ÀÏ Room C 14:35~14:40 Discussion ±èÀºÅÃ(°í½Å´ëÇб³)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:40~14:50 New Concept: OVsurg-2401 Intrathoracic approach of ovarian pleural metastasis (ÀÚÀ¯) ÀÌÁÖÇå(°æºÏ´ëº´¿ø)
Åä·Ð 05¿ù 10ÀÏ Room C 14:50~14:55 Discussion À±ÇüÁØ(ºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room A 15:00~15:40 Harnessing genomic insights in gynecological cancer in pursuit of improved patient outcome ¹Î°æÁø(°í´ë¾È»êº´¿ø)
Åä·Ð 05¿ù 10ÀÏ Room A 15:40~15:50 Discussion ±è¼º¹Î, À̽¹Ì(ÀÏ»êÂ÷º´¿ø, °è¸íÀǴ뵿»êÀÇ·á¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:00~16:10 Update of inclusion criteria discussed in the Steering Committee (ÀÚÀ¯) À̼ºÁ¾(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:10~16:25 Surgical video: da Vinci¢ç Robotic radical hysterectomy in the ROCC trial ¼ÛÀçÀ±(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:25~16:30 Strategies for colpotomy and tumor containment: Creation of vaginal cuff and closure (ÀÚÀ¯) À̼ºÁ¾(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:30~16:35 Strategies for colpotomy and tumor containment: Tape (ÀÚÀ¯) ±è¼º¹Î(ÀÏ»êÂ÷º´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:35~16:40 Strategies for colpotomy and tumor containment: Stapler (ÀÚÀ¯) °øÅ¿í(¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:40~16:45 Strategies for colpotomy and tumor containment: Uterine manipulation without Lumi (ÀÚÀ¯) ¹Ú¿µÇÑ(ÇѸ²¼º½Éº´¿ø)
Åä·Ð 05¿ù 10ÀÏ Room C 16:45~16:50 Discussion ±è¹Î±Ô(»ï¼ºÃ¢¿øº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 16:00~16:10 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK trial) / 1. Current Status & future issues (ÀÚÀ¯) ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 16:10~16:30 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK trial) /2. Protocol Updates (ver. 4.0) À±º¸¼º(ÀÏ»êÂ÷º´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 16:30~16:40 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK trial) /3. Tips for study procedure (ÀÚÀ¯) ¹®ÁöÇö(´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸)
Åä·Ð 05¿ù 10ÀÏ Room B 16:40~16:50 Discussion °øÅ¿í, ¼³¾Ö¶õ(¾ÆÁִ뺴¿ø, °í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 17:00~17:10 Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy with or without Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer : 1. Current Status & Dummy run study (ÀÚÀ¯) À§Âù¿ì(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 05¿ù 10ÀÏ Room B 17:10~17:20 Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy with or without Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer: 2. Suggestion of ¡°Pattern of care study on recurrent epithelial ovarian cancer (ÀÚÀ¯) ±èº¸¶ó(ÀÌ´ë¸ñµ¿º´¿ø)
Åä·Ð 05¿ù 10ÀÏ Room B 17:20~17:30 Discussion ÀÌ¿µÀç, À±ÇüÁØ(¼¼ºê¶õ½ºº´¿ø, ºÎ»ê´ëº´¿ø)